Venture capital has never raised or deployed more money than it has this year, and it has rarely been so dependent on so few names. Industry data counts 679 billion dollars of global venture funding in the first three quarters of 2026, the highest nine month total in that dataset. Behind that headline sits a market where a handful of companies, and a handful of managers, take most of the capital. For allocators who treat venture as a diversifier, the shape of the market matters as much as its size.
Record dollars, narrower field
Third quarter global venture funding came in at 159 billion dollars, up 53% from a year earlier and down 25% from the second quarter. Startups working on AI took 102 billion dollars of it, or 64%. A record 27 companies raised rounds of a billion dollars or more, up from 16 in the second quarter and 14 in the first, and together they accounted for about one third of all capital invested in the quarter.
The first quarter was more extreme. Four companies took nearly two thirds of global venture investment, and global deal count has trended down since the start of 2021 even as dollar totals hit records. More money is going to fewer companies.
Even the early rounds are growing
Concentration is not limited to late stage. The data shows rounds of 100 million dollars or more made up close to 90% of late stage financings in the third quarter, half of early stage financings, and about 20% of seed financings. Half of the quarter’s startup capital went to companies founded since 2022. Capital is moving quickly toward young companies with very large raises, rather than building slowly through a long list of smaller bets.
The money on the other side is concentrating too
U.S. data shows the same pattern. Deal value reached 515.8 billion dollars through the third quarter, about 44% above the full year record set in 2021, and AI accounted for a record 82.7% of it. On the fundraising side, established firms raised 88.2% of venture capital this year, the highest share in the dataset, and a single firm closed 23.8 billion dollars across multiple funds, more than 20% of all U.S. venture fundraising.
The authors of that data link this to exits. With few companies returning cash, limited partners are recommitting to the managers who already have, which consolidates fundraising around a small group of firms.
The exit question
Exits remain the weak point. Eighteen companies went public in the third quarter, mostly in healthcare, and a separate count found 17 venture backed North American listings raising just under 4 billion dollars combined, with no blockbuster technology debut. Two software companies that did transact sold for 1.3 billion and 1.4 billion dollars, at discounts of nearly 90% to their prior valuations. The data counts 992 active unicorns carrying a combined 5.7 trillion dollars in valuation, a figure that depends heavily on marks that have not yet met a buyer.
What this means for an allocator
Averages are becoming less useful in venture. When a few companies take a third of the capital in a quarter, fund outcomes depend on whether a manager owned those names and on whether those marks can be turned into cash. For investors building a venture allocation, a few questions follow naturally. How much of a fund’s value comes from one theme? How much of reported performance is unrealized? And what has the manager actually returned to its investors, not just what it has marked?
Vintage and stage diversification also take on more weight. A portfolio concentrated in the same handful of AI leaders looks diversified across funds and is not diversified across outcomes.
None of this argues against venture. It argues for treating the asset class as two markets: a concentrated group of very large companies and the managers who hold them, and a long tail of earlier stage businesses where the dynamics are different. The coming year will test whether public markets are ready to receive the largest private companies, and the answer will shape how both markets are valued.
